Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1354, 2002-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
TDF is a cost effective alternative in chronic hepatitis B infection
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 566, 2008-01 ,pp. :
Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Venlafaxine worthwhile for first-line depression treatment in the UK
Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. :
Docetaxel: clinical benefit in first-line treatment for NSCLC
Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. :